# The Determinants of Pharmaceutical R&D Expenditures: Evidence from Japan

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/the-determinants-of-pharmaceutical-r-and-amp-d-expenditures-evidence-from-japan/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jörg Mahlich,Thomas Roediger‐Schluga |
| Citations | 41 |
| DOI | 10.1007/s11151-006-0010-z |
| Fields | Business, Management and Accounting,Economics, Econometrics and Finance |
| Open Access | true |
| OA Status | green |
| OA URL | https://cris.maastrichtuniversity.nl/ws/files/618131/guid-d64de056-8b9d-4569-bbbc-74c3ef101271-ASSET1.0.pdf |
| OpenAlex ID | https://openalex.org/W2235133800 |
| Type | article |
| Year | 2006 |

## Paper authors

- [Jörg Mahlich](https://scholariq.org/researchers/jorg-mahlich/)

## Paper primary topic

- [Firm Innovation and Growth](https://scholariq.org/topics/firm-innovation-and-growth/)

## Paper topics

- [Firm Innovation and Growth](https://scholariq.org/topics/firm-innovation-and-growth/)
- [Innovation Policy and R&D](https://scholariq.org/topics/innovation-policy-and-r-and-d/)
- [Private Equity and Venture Capital](https://scholariq.org/topics/private-equity-and-venture-capital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.